These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34968126)

  • 1. Episodic foresight in multiple sclerosis.
    Manchery N; Henry JD; Blum S; Swayne A; Beer R; Rendell PG; Nangle MR
    Neuropsychology; 2022 Feb; 36(2):140-149. PubMed ID: 34968126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Episodic foresight and stroke.
    Lyons AD; Henry JD; Robinson G; Rendell PG; Suddendorf T
    Neuropsychology; 2019 Jan; 33(1):93-102. PubMed ID: 30614719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Episodic foresight and schizophrenia.
    Lyons AD; Henry JD; Rendell PG; Robinson G; Suddendorf T
    Br J Clin Psychol; 2016 Jun; 55(2):107-22. PubMed ID: 26175128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease disrupts the ability to initiate and apply episodic foresight.
    Coundouris SP; Henry JD; Rendell PG; Lehn AC
    J Int Neuropsychol Soc; 2023 Mar; 29(3):290-297. PubMed ID: 35504861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acting with the future in mind is impaired in long-term opiate users.
    Terrett G; Lyons A; Henry JD; Ryrie C; Suddendorf T; Rendell PG
    Psychopharmacology (Berl); 2017 Jan; 234(1):99-108. PubMed ID: 27714425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deconstructing the nature of episodic foresight deficits associated with chronic opiate use.
    Mercuri K; Terrett G; Bailey PE; Henry JD; Curran HV; Rendell PG
    Br J Clin Psychol; 2016 Nov; 55(4):401-413. PubMed ID: 26971561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Episodic Past, Future, and counterfactual thinking in Relapsing-Remitting Multiple sclerosis.
    Ayala OD; Banta D; Hovhannisyan M; Duarte L; Lozano A; García JR; Montañés P; Davis SW; De Brigard F
    Neuroimage Clin; 2022; 34():103033. PubMed ID: 35561552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective and objective sleep quality does not predict behavioural episodic foresight in younger or older adults.
    Demichelis OP; Grainger SA; McKay KT; Burr L; Kim J; Henry JD
    Sci Rep; 2023 Jan; 13(1):1056. PubMed ID: 36658258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Episodic foresight is impaired following acute alcohol intoxication.
    Elliott M; Terrett G; Curran HV; Rendell PG; Henry JD
    J Psychopharmacol; 2023 May; 37(5):490-497. PubMed ID: 36825668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-initiating and applying episodic foresight in middle childhood.
    Horner K; Coundouris SP; Terrett G; Rendell PG; Henry JD
    J Exp Child Psychol; 2023 Sep; 233():105696. PubMed ID: 37167847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episodic foresight and aging.
    Lyons AD; Henry JD; Rendell PG; Corballis MC; Suddendorf T
    Psychol Aging; 2014 Dec; 29(4):873-84. PubMed ID: 25365692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive function and oral health in relapsing-remitting multiple sclerosis.
    Manchery N; Henry JD; Swayne A; Beer R; Blum S; Nangle MR
    Clin Oral Investig; 2022 Mar; 26(3):2899-2907. PubMed ID: 34773142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in symptoms of depression between females and males with relapsing-remitting multiple sclerosis.
    Mayo CD; Lacey C; Gawryluk JR;
    Mult Scler Relat Disord; 2021 Jun; 51():102884. PubMed ID: 33799287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in correlates of fatigue between relapsing and progressive forms of multiple sclerosis.
    Herring TE; Alschuler KN; Knowles LM; Phillips KM; Morean WM; Turner AP; Ehde DM
    Mult Scler Relat Disord; 2021 Sep; 54():103109. PubMed ID: 34237561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid foot-tapping but not hand-tapping ability is different between relapsing-remitting and progressive multiple sclerosis.
    Sato S; Lim J; Miehm JD; Buonaccorsi J; Rajala C; Khalighinejad F; Ionete C; Kent JA; van Emmerik REA
    Mult Scler Relat Disord; 2020 Jun; 41():102031. PubMed ID: 32172213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust regional cerebral blood flow perfusion deficits in relapsing-remitting multiple sclerosis patients with executive function impairment.
    Messinis L; Apostolopoulos D; Spiridonidis T; Nasios G; Giazkoulidou A; Tsolaki M; Panagiotopoulos V
    Hell J Nucl Med; 2019; 22 Suppl():147-159. PubMed ID: 30877732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
    Costa SL; DeLuca J; Sandroff BM; Goverover Y; Chiaravalloti ND
    J Int Neuropsychol Soc; 2018 Feb; 24(2):139-146. PubMed ID: 28830576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral health-related quality of life is more strongly correlated with mental health than with oral health in relapsing-remitting multiple sclerosis.
    Nangle MR; Manchery N; Swayne A; Boocock H; Blum S; Henry JD
    J Oral Rehabil; 2023 Jan; 50(1):62-68. PubMed ID: 36301199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for relapsing-remitting multiple sclerosis.
    He D; Guo R; Zhang F; Zhang C; Dong S; Zhou H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009130. PubMed ID: 24310855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.